Patients Why “rare disease” is a regulatory label, not a patient real... Regulators define a rare disease by how many people have it, and the answer depends on who is counting.
News AZ and Oracle team up on AI platform for clinical trials AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research and patient care.
R&D Why clinical trials lose a quarter of their patients before ... Data fragmentation creates unnecessary burden on sponsors and the people clinical trials aim to serve.
Patients Moving beyond the pill: Unlocking value through engaged, emp... Creating an environment where the patient is recognised as an active participant in their care journey is critical.
Digital AI for the planet, AI for life sciences – with Patrick Leung Patrick Leung – chief technology officer at Faro Health – discusses how AI can transform clinical trials.
R&D Increasing trial efficiency: Adityo Prakash talks small data... Adityo Prakash, founder and CEO of Verseon, discusses small datasets, real-world scenarios, and organoids.
News Flagship joins three biotechs together to form Etcelera Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms from its portfolio.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
